FCE SOLUCIONES S.A.S: public contracts won without a rival in Colombia: 2 uncontested awards; 100% of its awards; 2 without a competition; 0 single bid.
Assay record ASY-CO-0LIXETO020 · Cite as: Assay Systems, “FCE SOLUCIONES S.A.S: public contracts won without a rival in Colombia”, https://assay-systems.com/register/co/uncontested/s/fce-soluciones-s-a-s/
FCE SOLUCIONES S.A.S won 2 of its 2 public contract awards in Colombia without a rival from 2025-02-06 to 2026-03-31: 2 without a competition and 0 after a competition that drew a single bid. 2 buyers awarded it without a rival, the largest ESE HOSPITAL FRANCISCO ELADIO BARRERA with 1.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
ESE HOSPITAL FRANCISCO ELADIO BARRERA gave FCE SOLUCIONES S.A.S 1 award: 1 without a competition, 0 after a competition with a single bid. First 2025-02-06, latest 2025-02-06.
ESE HOSPITAL SAN FRANCISCO DE ASÍS gave FCE SOLUCIONES S.A.S 1 award: 1 without a competition, 0 after a competition with a single bid. First 2026-03-31, latest 2026-03-31.
| Date | Buyer | How | Stated reason |
|---|---|---|---|
| 2026-03-31 | ESE HOSPITAL SAN FRANCISCO DE ASÍS CO1.PCCNTR.9426035 | No competition Contratación régimen especial | Regla aplicable |
| 2025-02-06 | ESE HOSPITAL FRANCISCO ELADIO BARRERA CO1.PCCNTR.7422383 | No competition Contratación régimen especial | Regla aplicable |
Every uncontested award in Colombia · All countries · FCE SOLUCIONES S.A.S in the register
Source: SECOP II, Colombia Compra Eficiente open data (datos.gov.co). Awards are matched to their buyer and supplier as published. Values in these notices often state a framework ceiling rather than a contract amount, so awards are counted, not summed. Updated 17 October 2026.